| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB2 CACNA1A GABRG3 SLC46A2 CACNA1E GJB1 GJB2 KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 CLCN5 MFSD14B KCND2 ABCA13 SLC26A2 GJB6 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 DISP2 SLC12A8 GRIK4 MCUB SLC9C2 ABCA8 ATP4B RYR3 ITPR1 | 6.95e-22 | 1180 | 72 | 33 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | NPC1 GABRB2 CACNA1A GABRG3 SLC46A2 CACNA1E GJB1 GJB2 KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 CLCN5 MFSD14B KCND2 ABCA13 SLC26A2 GJB6 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 DISP2 SLC12A8 GRIK4 MCUB SLC9C2 ABCA8 ATP4B RYR3 ITPR1 | 8.24e-22 | 1289 | 72 | 34 | GO:0005215 |
| GeneOntologyMolecularFunction | channel activity | GABRB2 CACNA1A GABRG3 CACNA1E GJB1 GJB2 KCNE4 KCNE3 TRPM5 CLCN5 KCND2 GJB6 SCN2A SCN4A SCN5A SCN7A PKD2L1 GRIK4 MCUB RYR3 ITPR1 | 9.82e-17 | 525 | 72 | 21 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB2 CACNA1A GABRG3 CACNA1E GJB1 GJB2 KCNE4 KCNE3 TRPM5 CLCN5 KCND2 GJB6 SCN2A SCN4A SCN5A SCN7A PKD2L1 GRIK4 MCUB RYR3 ITPR1 | 1.02e-16 | 526 | 72 | 21 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB2 CACNA1A GABRG3 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 CLCN5 KCND2 SLC26A2 SCN2A SCN4A SCN5A SCN7A PKD2L1 SLC12A8 GRIK4 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 2.20e-16 | 793 | 72 | 24 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB2 CACNA1A GABRG3 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 CLCN5 KCND2 SLC26A2 SCN2A SCN4A SCN5A SCN7A PKD2L1 SLC12A8 GRIK4 SLC9C2 ATP4B RYR3 ITPR1 | 1.02e-15 | 758 | 72 | 23 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB2 CACNA1A GABRG3 CACNA1E KCNE4 KCNE3 TRPM5 CLCN5 KCND2 SCN2A SCN4A SCN5A SCN7A PKD2L1 GRIK4 MCUB RYR3 ITPR1 | 3.05e-14 | 459 | 72 | 18 | GO:0005216 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A CACNA1E KCNE4 KCNE3 TRPM5 SLC30A5 KCND2 SCN2A SCN4A SCN5A SCN7A PKD2L1 SLC12A8 GRIK4 SLC9C2 ATP4B RYR3 ITPR1 | 3.81e-14 | 465 | 72 | 18 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 KCND2 SCN2A SCN4A SCN5A SCN7A PKD2L1 SLC12A8 GRIK4 SLC9C2 ATP4B RYR3 ITPR1 | 5.26e-13 | 627 | 72 | 19 | GO:0022890 |
| GeneOntologyMolecularFunction | gated channel activity | GABRB2 CACNA1A GABRG3 CACNA1E KCNE4 KCNE3 TRPM5 CLCN5 KCND2 SCN2A SCN7A PKD2L1 GRIK4 RYR3 ITPR1 | 8.02e-13 | 334 | 72 | 15 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 KCND2 SCN2A SCN4A SCN5A SCN7A PKD2L1 SLC12A8 GRIK4 SLC9C2 ATP4B RYR3 ITPR1 | 1.44e-12 | 664 | 72 | 19 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A CACNA1E KCNE4 KCNE3 TRPM5 KCND2 SCN2A SCN4A SCN5A SCN7A PKD2L1 GRIK4 RYR3 ITPR1 | 1.82e-11 | 343 | 72 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | sodium channel activity | 6.91e-10 | 52 | 72 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 GABRB2 GABRG3 TAS2R8 GPR21 P2RY12 OR5G3 OR13C8 OR13C3 OR6Q1 OR13C4 SCN7A OR2C3 TAS1R2 PKD2L1 GPR55 P2RY14 OR2S2 GRIK4 OR4D5 OR6M1 NOTCH1 | 1.09e-09 | 1353 | 72 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 8.74e-09 | 167 | 72 | 9 | GO:0015079 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.84e-07 | 171 | 72 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TAS2R8 GPR21 P2RY12 OR5G3 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 TAS1R2 GPR55 P2RY14 OR2S2 OR4D5 OR6M1 | 4.75e-07 | 884 | 72 | 15 | GO:0004930 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC46A2 ATP6V0D1 SLC30A5 CLCN5 ABCA13 SLC26A2 SLC6A19 SLC12A8 SLC9C2 ABCA8 ATP4B | 1.05e-06 | 477 | 72 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.19e-06 | 26 | 72 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 4.16e-06 | 182 | 72 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 4.47e-06 | 184 | 72 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 6.12e-06 | 193 | 72 | 7 | GO:0015276 | |
| GeneOntologyMolecularFunction | potassium channel activity | 6.82e-06 | 128 | 72 | 6 | GO:0005267 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 7.01e-06 | 197 | 72 | 7 | GO:0022834 | |
| GeneOntologyMolecularFunction | calcium channel activity | 7.13e-06 | 129 | 72 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.75e-05 | 151 | 72 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 2.39e-05 | 431 | 72 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 3.65e-05 | 172 | 72 | 6 | GO:0044325 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 8.88e-05 | 125 | 72 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 9.47e-05 | 296 | 72 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | gap junction channel activity | 9.77e-05 | 25 | 72 | 3 | GO:0005243 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.51e-04 | 140 | 72 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.88e-04 | 31 | 72 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.15e-04 | 151 | 72 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.22e-04 | 152 | 72 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | taste receptor activity | 2.27e-04 | 33 | 72 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | wide pore channel activity | 3.20e-04 | 37 | 72 | 3 | GO:0022829 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 3.82e-04 | 171 | 72 | 5 | GO:0015103 | |
| GeneOntologyMolecularFunction | gap junction channel activity involved in cell communication by electrical coupling | 4.54e-04 | 9 | 72 | 2 | GO:1903763 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 4.54e-04 | 9 | 72 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 4.54e-04 | 9 | 72 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.50e-04 | 109 | 72 | 4 | GO:0042626 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 6.92e-04 | 48 | 72 | 3 | GO:0008200 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 7.80e-04 | 50 | 72 | 3 | GO:0016248 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization | 8.27e-04 | 12 | 72 | 2 | GO:1902282 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 8.27e-04 | 51 | 72 | 3 | GO:0141110 | |
| GeneOntologyMolecularFunction | calcium channel inhibitor activity | 9.75e-04 | 13 | 72 | 2 | GO:0019855 | |
| GeneOntologyMolecularFunction | G protein-coupled purinergic nucleotide receptor activity | 9.75e-04 | 13 | 72 | 2 | GO:0045028 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.13e-03 | 14 | 72 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.14e-03 | 57 | 72 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization | 1.31e-03 | 15 | 72 | 2 | GO:0086008 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.33e-03 | 60 | 72 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.45e-03 | 230 | 72 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.56e-03 | 138 | 72 | 4 | GO:0015297 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.67e-03 | 65 | 72 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.67e-03 | 65 | 72 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 1.89e-03 | 18 | 72 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.89e-03 | 18 | 72 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 2.11e-03 | 19 | 72 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.52e-03 | 75 | 72 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.72e-03 | 77 | 72 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 2.80e-03 | 162 | 72 | 4 | GO:0099106 | |
| GeneOntologyMolecularFunction | nucleotide receptor activity | 2.83e-03 | 22 | 72 | 2 | GO:0016502 | |
| GeneOntologyMolecularFunction | purinergic nucleotide receptor activity | 2.83e-03 | 22 | 72 | 2 | GO:0001614 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 2.83e-03 | 22 | 72 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.36e-03 | 24 | 72 | 2 | GO:0099507 | |
| GeneOntologyMolecularFunction | channel regulator activity | 3.61e-03 | 174 | 72 | 4 | GO:0016247 | |
| GeneOntologyMolecularFunction | chloride channel activity | 3.71e-03 | 86 | 72 | 3 | GO:0005254 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 3.84e-03 | 177 | 72 | 4 | GO:0141108 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 3.92e-03 | 178 | 72 | 4 | GO:0015399 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 4.25e-03 | 27 | 72 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 4.25e-03 | 27 | 72 | 2 | GO:0005227 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 4.56e-03 | 28 | 72 | 2 | GO:0005251 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 4.62e-03 | 301 | 72 | 5 | GO:0022853 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 4.76e-03 | 188 | 72 | 4 | GO:0015078 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 5.57e-03 | 31 | 72 | 2 | GO:0022839 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 5.66e-03 | 100 | 72 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | alcohol binding | 5.98e-03 | 102 | 72 | 3 | GO:0043178 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 5.98e-03 | 102 | 72 | 3 | GO:0005249 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 6.14e-03 | 103 | 72 | 3 | GO:0005253 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 6.30e-03 | 33 | 72 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 1.05e-02 | 43 | 72 | 2 | GO:0140828 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB2 CACNA1A CAB39 GABRG3 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 CLCN5 P2RY12 KCND2 SLC26A2 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 SLC12A8 GRIK4 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 2.03e-16 | 1115 | 72 | 27 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | GABRB2 CACNA1A CAB39 GABRG3 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 CLCN5 P2RY12 KCND2 SLC26A2 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 SLC12A8 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 2.38e-16 | 1017 | 72 | 26 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB2 CACNA1A CAB39 GABRG3 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 CLCN5 P2RY12 KCND2 SLC26A2 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 SLC12A8 GRIK4 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 3.41e-14 | 1374 | 72 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A CAB39 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 P2RY12 KCND2 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 SLC12A8 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 3.38e-13 | 922 | 72 | 22 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A CAB39 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 P2RY12 KCND2 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 SLC12A8 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 5.20e-13 | 942 | 72 | 22 | GO:0098655 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A CAB39 CACNA1E KCNE4 KCNE3 TRPM5 SLC30A5 P2RY12 KCND2 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 SLC12A8 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 1.48e-11 | 1000 | 72 | 21 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A CAB39 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 SLC30A5 P2RY12 KCND2 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 SLC12A8 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 2.98e-11 | 1157 | 72 | 22 | GO:0006812 |
| GeneOntologyBiologicalProcess | potassium ion transport | CAB39 KCNE4 KCNE3 TRPM5 P2RY12 KCND2 SCN4A PKD2L1 SLC12A8 SLC9C2 ATP4B | 2.54e-09 | 272 | 72 | 11 | GO:0006813 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | CAB39 KCNE4 KCNE3 TRPM5 P2RY12 KCND2 PKD2L1 SLC12A8 SLC9C2 ATP4B | 7.78e-09 | 232 | 72 | 10 | GO:0071805 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.19e-08 | 87 | 72 | 7 | GO:0086001 | |
| GeneOntologyBiologicalProcess | sodium ion transport | KCNE3 TRPM5 SCN2A SCN4A SCN5A SCN7A SLC6A19 PKD2L1 SLC9C2 ATP4B | 3.91e-08 | 275 | 72 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 4.46e-08 | 208 | 72 | 9 | GO:0035725 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 7.71e-08 | 62 | 72 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | TAS2R8 OR5G3 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 TAS1R2 PKD2L1 OR2S2 OR4D5 OR6M1 | 1.07e-07 | 485 | 72 | 12 | GO:0050907 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | TAS2R8 OR5G3 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 TAS1R2 PKD2L1 OR2S2 OR4D5 OR6M1 | 2.45e-07 | 524 | 72 | 12 | GO:0009593 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | TAS2R8 OR5G3 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 TAS1R2 PKD2L1 OR2S2 OR4D5 OR6M1 | 3.87e-07 | 547 | 72 | 12 | GO:0007606 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 6.41e-07 | 142 | 72 | 7 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 6.41e-07 | 142 | 72 | 7 | GO:0098659 | |
| GeneOntologyBiologicalProcess | sensory perception | CACNA1E GJB2 TAS2R8 KCND2 OR5G3 OR13C8 OR13C3 OR6Q1 GJB6 OR13C4 OR2C3 TAS1R2 PKD2L1 OR2S2 OR4D5 OR6M1 | 6.66e-07 | 1072 | 72 | 16 | GO:0007600 |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | TAS2R8 OR5G3 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 TAS1R2 PKD2L1 OR2S2 OR4D5 OR6M1 | 7.47e-07 | 582 | 72 | 12 | GO:0050906 |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 8.78e-07 | 93 | 72 | 6 | GO:0086003 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.37e-06 | 230 | 72 | 8 | GO:0098739 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.61e-06 | 112 | 72 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | GABRB2 CACNA1A GABRG3 KCNE4 KCNE3 KCND2 SCN2A SCN4A SCN5A SCN7A GRIK4 | 3.55e-06 | 559 | 72 | 11 | GO:0042391 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | TAS2R8 GPR21 P2RY12 OR5G3 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 TAS1R2 GPR55 P2RY14 OR2S2 OR4D5 ADCY2 OR6M1 ITPR1 | 4.52e-06 | 1395 | 72 | 17 | GO:0007186 |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 5.42e-06 | 127 | 72 | 6 | GO:0070252 | |
| GeneOntologyBiologicalProcess | action potential | 6.48e-06 | 201 | 72 | 7 | GO:0001508 | |
| GeneOntologyBiologicalProcess | detection of stimulus | TAS2R8 OR5G3 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 TAS1R2 PKD2L1 OR2S2 OR4D5 OR6M1 | 6.91e-06 | 722 | 72 | 12 | GO:0051606 |
| GeneOntologyBiologicalProcess | heart contraction | 9.28e-06 | 298 | 72 | 8 | GO:0060047 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.07e-05 | 217 | 72 | 7 | GO:0006941 | |
| GeneOntologyBiologicalProcess | heart process | 1.21e-05 | 309 | 72 | 8 | GO:0003015 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.58e-05 | 153 | 72 | 6 | GO:0030048 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 1.89e-05 | 432 | 72 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | NPC1 CACNA1A CACNA1E KCNE3 ATP6V0D1 SLC30A5 GPR21 GJB6 SCN7A SLC12A8 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 2.19e-05 | 1249 | 72 | 15 | GO:0048878 |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.59e-05 | 167 | 72 | 6 | GO:0060048 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1A CACNA1E KCNE3 ATP6V0D1 SLC30A5 GJB6 SCN7A SLC12A8 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 3.07e-05 | 981 | 72 | 13 | GO:0019725 |
| GeneOntologyBiologicalProcess | sensory perception of smell | 3.37e-05 | 465 | 72 | 9 | GO:0007608 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1A KCNE3 ATP6V0D1 SLC30A5 SCN7A SLC12A8 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 3.63e-05 | 717 | 72 | 11 | GO:0050801 |
| GeneOntologyBiologicalProcess | gap junction assembly | 3.80e-05 | 19 | 72 | 3 | GO:0016264 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1A CACNA1E KCNE3 ATP6V0D1 SLC30A5 GJB6 SCN7A MCUB SLC9C2 ATP4B RYR3 ITPR1 | 4.19e-05 | 866 | 72 | 12 | GO:0055082 |
| GeneOntologyBiologicalProcess | membrane repolarization | 4.37e-05 | 56 | 72 | 4 | GO:0086009 | |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 4.52e-05 | 112 | 72 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | CACNA1A KCNE3 ATP6V0D1 SLC30A5 SCN7A SLC12A8 MCUB ATP4B RYR3 ITPR1 | 5.76e-05 | 622 | 72 | 10 | GO:0098771 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1A KCNE3 ATP6V0D1 SLC30A5 SCN7A MCUB SLC9C2 ATP4B RYR3 ITPR1 | 5.76e-05 | 622 | 72 | 10 | GO:0006873 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 6.56e-05 | 392 | 72 | 8 | GO:0070588 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 6.96e-05 | 63 | 72 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | muscle contraction | 7.56e-05 | 400 | 72 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | import into cell | NPC1 CACNA1A SLC46A2 GPM6B CACNA1E SLC30A5 CLCN5 ABCA13 SCN5A MYO1F SLC12A8 SLC9C2 ATP4B | 7.77e-05 | 1074 | 72 | 13 | GO:0098657 |
| GeneOntologyBiologicalProcess | chloride transport | 8.54e-05 | 128 | 72 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell membrane repolarization | 8.88e-05 | 25 | 72 | 3 | GO:0060307 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 8.88e-05 | 25 | 72 | 3 | GO:0055064 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.06e-04 | 134 | 72 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.17e-04 | 547 | 72 | 9 | GO:0003012 | |
| GeneOntologyBiologicalProcess | epididymis development | 1.19e-04 | 5 | 72 | 2 | GO:1905867 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 1.25e-04 | 28 | 72 | 3 | GO:0055081 | |
| GeneOntologyBiologicalProcess | negative regulation of potassium ion transmembrane transporter activity | 1.40e-04 | 29 | 72 | 3 | GO:1901017 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell membrane repolarization | 1.55e-04 | 30 | 72 | 3 | GO:0099625 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell membrane repolarization | 1.55e-04 | 30 | 72 | 3 | GO:0099623 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1A ATP6V0D1 SLC30A5 SCN7A SLC12A8 MCUB SLC9C2 ATP4B RYR3 ITPR1 | 1.62e-04 | 705 | 72 | 10 | GO:0055080 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.97e-04 | 153 | 72 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | gamma-aminobutyric acid signaling pathway | 2.46e-04 | 35 | 72 | 3 | GO:0007214 | |
| GeneOntologyBiologicalProcess | negative regulation of potassium ion transmembrane transport | 2.46e-04 | 35 | 72 | 3 | GO:1901380 | |
| GeneOntologyBiologicalProcess | gap junction-mediated intercellular transport | 2.50e-04 | 7 | 72 | 2 | GO:1990349 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 2.67e-04 | 611 | 72 | 9 | GO:0030003 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.68e-04 | 36 | 72 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle cell action potential | 2.91e-04 | 37 | 72 | 3 | GO:0086005 | |
| GeneOntologyBiologicalProcess | cardiac conduction system development | 3.67e-04 | 40 | 72 | 3 | GO:0003161 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 3.90e-04 | 509 | 72 | 8 | GO:0006816 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell membrane repolarization | 3.95e-04 | 41 | 72 | 3 | GO:0099622 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 3.95e-04 | 41 | 72 | 3 | GO:0086091 | |
| GeneOntologyBiologicalProcess | regulation of membrane repolarization | 3.95e-04 | 41 | 72 | 3 | GO:0060306 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | 4.18e-04 | 180 | 72 | 5 | GO:0015698 | |
| GeneOntologyBiologicalProcess | protein lipidation | 4.32e-04 | 101 | 72 | 4 | GO:0006497 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 4.50e-04 | 183 | 72 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 5.18e-04 | 106 | 72 | 4 | GO:0042158 | |
| GeneOntologyBiologicalProcess | negative regulation of potassium ion transport | 5.56e-04 | 46 | 72 | 3 | GO:0043267 | |
| GeneOntologyBiologicalProcess | intercellular transport | 6.48e-04 | 11 | 72 | 2 | GO:0010496 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of taste | 7.11e-04 | 50 | 72 | 3 | GO:0050912 | |
| GeneOntologyBiologicalProcess | negative regulation of cation transmembrane transport | 7.28e-04 | 116 | 72 | 4 | GO:1904063 | |
| GeneOntologyBiologicalProcess | negative regulation of delayed rectifier potassium channel activity | 7.75e-04 | 12 | 72 | 2 | GO:1902260 | |
| GeneOntologyBiologicalProcess | foregut morphogenesis | 7.75e-04 | 12 | 72 | 2 | GO:0007440 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 8.52e-04 | 121 | 72 | 4 | GO:0051899 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 8.87e-04 | 577 | 72 | 8 | GO:0043269 | |
| GeneOntologyBiologicalProcess | G protein-coupled purinergic nucleotide receptor signaling pathway | 9.14e-04 | 13 | 72 | 2 | GO:0035589 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transmembrane transport | 9.34e-04 | 124 | 72 | 4 | GO:0034766 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 1.08e-03 | 129 | 72 | 4 | GO:0002027 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion transmembrane transporter activity | 1.39e-03 | 63 | 72 | 3 | GO:1901016 | |
| GeneOntologyBiologicalProcess | intracellular chloride ion homeostasis | 1.40e-03 | 16 | 72 | 2 | GO:0030644 | |
| GeneOntologyBiologicalProcess | membrane repolarization during ventricular cardiac muscle cell action potential | 1.58e-03 | 17 | 72 | 2 | GO:0098915 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic anion homeostasis | 1.58e-03 | 17 | 72 | 2 | GO:0030002 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 1.65e-03 | 493 | 72 | 7 | GO:0010959 | |
| GeneOntologyBiologicalProcess | lipoprotein metabolic process | 1.75e-03 | 147 | 72 | 4 | GO:0042157 | |
| GeneOntologyBiologicalProcess | calcium import into the mitochondrion | 1.77e-03 | 18 | 72 | 2 | GO:0036444 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 1.78e-03 | 249 | 72 | 5 | GO:0008016 | |
| GeneOntologyBiologicalProcess | musculoskeletal movement | 1.81e-03 | 69 | 72 | 3 | GO:0050881 | |
| GeneOntologyBiologicalProcess | blood circulation | 1.85e-03 | 648 | 72 | 8 | GO:0008015 | |
| GeneOntologyBiologicalProcess | sensory perception of taste | 1.89e-03 | 70 | 72 | 3 | GO:0050909 | |
| GeneOntologyBiologicalProcess | cellular response to osmotic stress | 2.05e-03 | 72 | 72 | 3 | GO:0071470 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | 2.11e-03 | 380 | 72 | 6 | GO:1904062 | |
| GeneOntologyBiologicalProcess | multicellular organismal movement | 2.13e-03 | 73 | 72 | 3 | GO:0050879 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | GABRB2 CACNA1A GABRG3 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 KCND2 SCN2A SCN4A SCN5A SCN7A PKD2L1 GRIK4 MCUB ATP4B RYR3 | 1.31e-13 | 523 | 72 | 18 | GO:1902495 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB2 CACNA1A GABRG3 CACNA1E KCNE4 KCNE3 TRPM5 KCND2 SCN2A SCN4A SCN5A SCN7A PKD2L1 GRIK4 MCUB RYR3 | 1.56e-13 | 378 | 72 | 16 | GO:0034702 |
| GeneOntologyCellularComponent | transporter complex | GABRB2 CACNA1A GABRG3 CACNA1E KCNE4 KCNE3 ATP6V0D1 TRPM5 KCND2 SCN2A SCN4A SCN5A SCN7A PKD2L1 GRIK4 MCUB ATP4B RYR3 | 3.08e-13 | 550 | 72 | 18 | GO:1990351 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1A CACNA1E KCNE4 KCNE3 KCND2 SCN2A SCN4A SCN5A SCN7A PKD2L1 GRIK4 MCUB RYR3 | 1.30e-12 | 235 | 72 | 13 | GO:0034703 |
| GeneOntologyCellularComponent | membrane protein complex | GABRB2 CACNA1A GABRG3 APH1B CACNA1E GJB1 GJB2 KCNE4 KCNE3 ATP6V0D1 TRPM5 KCND2 GJB6 SCN2A SCN4A MARCHF6 SCN5A SCN7A PKD2L1 GRIK4 PIGU MCUB ATP4B RYR3 | 7.81e-11 | 1498 | 72 | 24 | GO:0098796 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A APH1B CACNA1E GJB1 GJB2 KCNE4 KCNE3 ATP6V0D1 KCND2 GJB6 SCN2A SCN4A SCN5A SCN7A GRIK4 ATP4B | 7.74e-09 | 785 | 72 | 16 | GO:0098797 |
| GeneOntologyCellularComponent | sodium channel complex | 4.69e-08 | 29 | 72 | 5 | GO:0034706 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.98e-07 | 17 | 72 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | calcium channel complex | 5.27e-06 | 73 | 72 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | apical part of cell | KCNE4 ATP6V0D1 SLC30A5 CLCN5 SLC26A2 GJB6 UPK1B SLC6A19 ATP4B NOTCH1 | 3.40e-05 | 592 | 72 | 10 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | KCNE4 ATP6V0D1 SLC30A5 SLC26A2 GJB6 UPK1B SLC6A19 ATP4B NOTCH1 | 4.35e-05 | 487 | 72 | 9 | GO:0016324 |
| GeneOntologyCellularComponent | connexin complex | 5.76e-05 | 22 | 72 | 3 | GO:0005922 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB2 CACNA1A GABRG3 CACNA1E KCND2 SCN2A GRIK4 NOTCH1 ITPR1 | 1.71e-04 | 583 | 72 | 9 | GO:0097060 |
| GeneOntologyCellularComponent | membrane raft | 2.47e-04 | 362 | 72 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 2.55e-04 | 364 | 72 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 2.56e-04 | 164 | 72 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | gap junction | 2.80e-04 | 37 | 72 | 3 | GO:0005921 | |
| GeneOntologyCellularComponent | potassium channel complex | 4.59e-04 | 104 | 72 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 4.85e-04 | 405 | 72 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | cell body membrane | 5.70e-04 | 47 | 72 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | perikaryon | 1.03e-03 | 223 | 72 | 5 | GO:0043204 | |
| GeneOntologyCellularComponent | Z disc | 1.84e-03 | 151 | 72 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 1.93e-03 | 19 | 72 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 2.35e-03 | 21 | 72 | 2 | GO:1902710 | |
| GeneOntologyCellularComponent | T-tubule | 2.57e-03 | 79 | 72 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | I band | 2.59e-03 | 166 | 72 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.67e-03 | 277 | 72 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | cell projection membrane | 3.68e-03 | 431 | 72 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 3.71e-03 | 90 | 72 | 3 | GO:0016328 | |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 3.83e-03 | 91 | 72 | 3 | GO:0008076 | |
| GeneOntologyCellularComponent | sarcolemma | 4.20e-03 | 190 | 72 | 4 | GO:0042383 | |
| GeneOntologyCellularComponent | cell body | 4.50e-03 | 929 | 72 | 9 | GO:0044297 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.13e-03 | 201 | 72 | 4 | GO:0099634 | |
| GeneOntologyCellularComponent | caveola | 6.66e-03 | 111 | 72 | 3 | GO:0005901 | |
| GeneOntologyCellularComponent | filamentous actin | 7.59e-03 | 38 | 72 | 2 | GO:0031941 | |
| HumanPheno | Abnormal nervous system electrophysiology | GABRB2 SEMA6B CACNA1A CACNA1E GJB1 GJB2 KCNE3 GJB6 SCN2A SCN4A MARCHF6 SLC6A19 MED13L NOTCH1 ITPR1 | 3.61e-06 | 924 | 25 | 15 | HP:0001311 |
| HumanPheno | Abnormality of the calcaneus | 6.57e-06 | 57 | 25 | 5 | HP:0008364 | |
| HumanPheno | Abnormality of central nervous system electrophysiology | GABRB2 SEMA6B CACNA1A CACNA1E GJB2 GJB6 SCN2A MARCHF6 SLC6A19 MED13L NOTCH1 ITPR1 | 6.61e-05 | 738 | 25 | 12 | HP:0030178 |
| HumanPheno | Lip fissure | 6.92e-05 | 3 | 25 | 2 | HP:0031250 | |
| HumanPheno | Phenotypic variability | 7.06e-05 | 224 | 25 | 7 | HP:0003812 | |
| MousePheno | abnormal gustatory system physiology | 1.72e-06 | 22 | 57 | 4 | MP:0001985 | |
| MousePheno | abnormal channel response | 9.31e-06 | 33 | 57 | 4 | MP:0003484 | |
| MousePheno | hyperthreoninuria | 1.63e-05 | 2 | 57 | 2 | MP:0020406 | |
| MousePheno | abnormal taste sensitivity | 5.95e-05 | 19 | 57 | 3 | MP:0001986 | |
| MousePheno | hyperglutaminuria | 9.75e-05 | 4 | 57 | 2 | MP:0030617 | |
| MousePheno | taste/olfaction phenotype | 1.52e-04 | 125 | 57 | 5 | MP:0005394 | |
| MousePheno | increased threonine level | 1.62e-04 | 5 | 57 | 2 | MP:0030700 | |
| MousePheno | increased muscle relaxation | 1.62e-04 | 5 | 57 | 2 | MP:0004037 | |
| MousePheno | abnormal threonine level | 1.62e-04 | 5 | 57 | 2 | MP:0030699 | |
| MousePheno | increased glycine level | 3.39e-04 | 7 | 57 | 2 | MP:0030658 | |
| Domain | Ion_trans_dom | CACNA1A CACNA1E TRPM5 KCND2 SCN2A SCN4A SCN5A SCN7A RYR3 ITPR1 | 1.62e-11 | 114 | 71 | 10 | IPR005821 |
| Domain | Ion_trans | CACNA1A CACNA1E TRPM5 KCND2 SCN2A SCN4A SCN5A SCN7A RYR3 ITPR1 | 1.62e-11 | 114 | 71 | 10 | PF00520 |
| Domain | Channel_four-helix_dom | 4.14e-11 | 57 | 71 | 8 | IPR027359 | |
| Domain | - | 4.14e-11 | 57 | 71 | 8 | 1.20.120.350 | |
| Domain | Na_channel_asu | 3.96e-08 | 10 | 71 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 3.96e-08 | 10 | 71 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 3.96e-08 | 10 | 71 | 4 | PF06512 | |
| Domain | GPCR_Rhodpsn_7TM | TAS2R8 GPR21 P2RY12 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 GPR55 P2RY14 OR2S2 OR4D5 OR6M1 | 1.24e-06 | 670 | 71 | 13 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_2 | TAS2R8 GPR21 P2RY12 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 GPR55 P2RY14 OR2S2 OR4D5 OR6M1 | 1.75e-06 | 691 | 71 | 13 | PS50262 |
| Domain | GPCR_Rhodpsn | TAS2R8 GPR21 P2RY12 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 GPR55 P2RY14 OR2S2 OR4D5 OR6M1 | 1.77e-06 | 692 | 71 | 13 | IPR000276 |
| Domain | 7tm_1 | GPR21 P2RY12 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 GPR55 P2RY14 OR2S2 OR4D5 OR6M1 | 8.42e-06 | 677 | 71 | 12 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR21 P2RY12 OR13C8 OR13C3 OR6Q1 OR13C4 OR2C3 GPR55 P2RY14 OR2S2 OR4D5 OR6M1 | 9.47e-06 | 685 | 71 | 12 | PS00237 |
| Domain | IQ | 1.41e-05 | 81 | 71 | 5 | SM00015 | |
| Domain | SSD | 1.47e-05 | 13 | 71 | 3 | PS50156 | |
| Domain | SSD | 1.47e-05 | 13 | 71 | 3 | IPR000731 | |
| Domain | IQ_motif_EF-hand-BS | 2.35e-05 | 90 | 71 | 5 | IPR000048 | |
| Domain | CONNEXINS_1 | 4.88e-05 | 19 | 71 | 3 | PS00407 | |
| Domain | Connexin_N | 5.73e-05 | 20 | 71 | 3 | IPR013092 | |
| Domain | CONNEXINS_2 | 5.73e-05 | 20 | 71 | 3 | PS00408 | |
| Domain | Connexin | 5.73e-05 | 20 | 71 | 3 | PF00029 | |
| Domain | Connexin_CCC | 5.73e-05 | 20 | 71 | 3 | SM01089 | |
| Domain | Connexin_CS | 5.73e-05 | 20 | 71 | 3 | IPR017990 | |
| Domain | Connexin | 5.73e-05 | 20 | 71 | 3 | IPR000500 | |
| Domain | Connexin_CCC | 5.73e-05 | 20 | 71 | 3 | IPR019570 | |
| Domain | CNX | 5.73e-05 | 20 | 71 | 3 | SM00037 | |
| Domain | Olfact_rcpt | 1.20e-04 | 393 | 71 | 8 | IPR000725 | |
| Domain | Tet-R_TetA/multi-R_MdtG | 1.41e-04 | 5 | 71 | 2 | IPR001958 | |
| Domain | K_chnl_KCNE | 2.12e-04 | 6 | 71 | 2 | IPR000369 | |
| Domain | RIH_assoc | 2.12e-04 | 6 | 71 | 2 | PF08454 | |
| Domain | RIH_assoc-dom | 2.12e-04 | 6 | 71 | 2 | IPR013662 | |
| Domain | RYDR_ITPR | 2.12e-04 | 6 | 71 | 2 | PF01365 | |
| Domain | RIH_dom | 2.12e-04 | 6 | 71 | 2 | IPR000699 | |
| Domain | Na_trans_cytopl | 2.12e-04 | 6 | 71 | 2 | PF11933 | |
| Domain | Ins145_P3_rcpt | 2.12e-04 | 6 | 71 | 2 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.12e-04 | 6 | 71 | 2 | IPR015925 | |
| Domain | Ins145_P3_rec | 2.12e-04 | 6 | 71 | 2 | PF08709 | |
| Domain | ISK_Channel | 2.12e-04 | 6 | 71 | 2 | PF02060 | |
| Domain | Na_trans_cytopl | 2.12e-04 | 6 | 71 | 2 | IPR024583 | |
| Domain | - | 2.12e-04 | 6 | 71 | 2 | 1.25.10.30 | |
| Domain | GPHH_dom | 2.96e-04 | 7 | 71 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 2.96e-04 | 7 | 71 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 2.96e-04 | 7 | 71 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 2.96e-04 | 7 | 71 | 2 | PF08763 | |
| Domain | GPHH | 2.96e-04 | 7 | 71 | 2 | PF16905 | |
| Domain | IQ | 4.34e-04 | 93 | 71 | 4 | PS50096 | |
| Domain | Ptc/Disp | 5.04e-04 | 9 | 71 | 2 | IPR003392 | |
| Domain | Patched | 5.04e-04 | 9 | 71 | 2 | PF02460 | |
| Domain | MIR | 6.29e-04 | 10 | 71 | 2 | PS50919 | |
| Domain | MIR | 6.29e-04 | 10 | 71 | 2 | PF02815 | |
| Domain | MIR | 6.29e-04 | 10 | 71 | 2 | SM00472 | |
| Domain | VDCCAlpha1 | 6.29e-04 | 10 | 71 | 2 | IPR002077 | |
| Domain | MIR_motif | 6.29e-04 | 10 | 71 | 2 | IPR016093 | |
| Domain | ABC_A | 9.18e-04 | 12 | 71 | 2 | IPR026082 | |
| Domain | GABAA/Glycine_rcpt | 3.42e-03 | 23 | 71 | 2 | IPR006028 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.11e-09 | 130 | 59 | 9 | M27454 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.50e-07 | 203 | 59 | 9 | M5485 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.63e-07 | 147 | 59 | 8 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 2.01e-07 | 151 | 59 | 8 | M39329 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | TAS2R8 TRPM5 OR5G3 OR13C8 OR13C3 OR6Q1 OR13C4 SCN2A OR2C3 TAS1R2 OR2S2 OR4D5 OR6M1 | 1.69e-06 | 636 | 59 | 13 | M41834 |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 8.00e-06 | 31 | 59 | 4 | M877 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 ATP6V0D1 TRPM5 SLC30A5 CLCN5 SLC26A2 SLC6A19 MCUB SLC9C2 ADCY2 ABCA8 ATP4B RYR3 | 8.38e-06 | 736 | 59 | 13 | M27287 |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 9.12e-06 | 32 | 59 | 4 | M27455 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.12e-05 | 11 | 59 | 3 | M47958 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 4.32e-05 | 47 | 59 | 4 | M42524 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 5.39e-05 | 417 | 59 | 9 | M4072 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 6.45e-05 | 52 | 59 | 4 | M5785 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 6.91e-05 | 103 | 59 | 5 | MM15196 | |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 1.01e-04 | 22 | 59 | 3 | M39795 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | NPC1 ATP6V0D1 TRPM5 SLC30A5 CLCN5 SLC26A2 SLC6A19 MCUB ABCA8 ATP4B RYR3 | 1.03e-04 | 681 | 59 | 11 | MM14985 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 1.12e-04 | 183 | 59 | 6 | M997 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 2.03e-04 | 389 | 59 | 8 | M14091 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 2.44e-04 | 211 | 59 | 6 | MM14502 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 3.17e-04 | 32 | 59 | 3 | MM14730 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 3.22e-04 | 314 | 59 | 7 | M600 | |
| Pathway | REACTOME_PHASE_3_RAPID_REPOLARISATION | 4.74e-04 | 8 | 59 | 2 | MM15195 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 4.75e-04 | 335 | 59 | 7 | MM14503 | |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 5.29e-04 | 38 | 59 | 3 | M14981 | |
| Pathway | REACTOME_PHASE_3_RAPID_REPOLARISATION | 6.08e-04 | 9 | 59 | 2 | M27453 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 6.21e-04 | 165 | 59 | 5 | MM15026 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 8.16e-04 | 44 | 59 | 3 | MM14606 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 8.32e-04 | 176 | 59 | 5 | MM15718 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 8.75e-04 | 178 | 59 | 5 | M2890 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 8.99e-04 | 270 | 59 | 6 | M15514 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 9.24e-04 | 11 | 59 | 2 | MM15049 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 9.24e-04 | 11 | 59 | 2 | MM14498 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 9.24e-04 | 11 | 59 | 2 | M47865 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 9.24e-04 | 11 | 59 | 2 | M26913 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.00e-03 | 106 | 59 | 4 | M27200 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.07e-03 | 108 | 59 | 4 | M17034 | |
| Pathway | REACTOME_P2Y_RECEPTORS | 1.11e-03 | 12 | 59 | 2 | M10960 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 1.26e-03 | 51 | 59 | 3 | M26972 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 1.30e-03 | 13 | 59 | 2 | M39589 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 1.52e-03 | 14 | 59 | 2 | MM15198 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.57e-03 | 411 | 59 | 7 | M735 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 1.63e-03 | 121 | 59 | 4 | M872 | |
| Pathway | REACTOME_PHASE_2_PLATEAU_PHASE | 1.75e-03 | 15 | 59 | 2 | M27456 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB4 | 1.82e-03 | 58 | 59 | 3 | M544 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 1.99e-03 | 16 | 59 | 2 | M6786 | |
| Pathway | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | 1.99e-03 | 16 | 59 | 2 | MM15050 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.01e-03 | 60 | 59 | 3 | M976 | |
| Pathway | REACTOME_GABA_RECEPTOR_ACTIVATION | 2.01e-03 | 60 | 59 | 3 | MM15708 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 2.11e-03 | 61 | 59 | 3 | MM15071 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.81e-03 | 19 | 59 | 2 | M47760 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.08e-03 | 144 | 59 | 4 | MM14501 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.38e-03 | 72 | 59 | 3 | MM14631 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.56e-11 | 139 | 73 | 9 | 16985003 | |
| Pubmed | Organization and evolutionary relatedness of OR37 olfactory receptor genes in mouse and human. | 8.73e-09 | 12 | 73 | 4 | 12906860 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 22098503 | ||
| Pubmed | 8.84e-08 | 5 | 73 | 3 | 17724025 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 20089884 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 16382098 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 19864490 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 15746173 | ||
| Pubmed | 7.38e-07 | 9 | 73 | 3 | 14595769 | ||
| Pubmed | 1.05e-06 | 10 | 73 | 3 | 19523148 | ||
| Pubmed | Expression of connexins in embryonic mouse neocortical development. | 1.05e-06 | 10 | 73 | 3 | 17640036 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.25e-06 | 38 | 73 | 4 | 30786075 | |
| Pubmed | 1.93e-06 | 12 | 73 | 3 | 25256039 | ||
| Pubmed | 2.00e-06 | 541 | 73 | 9 | 14983052 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 31162818 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 28012540 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19723508 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23503914 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23700267 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25715449 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 20236118 | ||
| Pubmed | Connexin 26 variants and auditory neuropathy/dys-synchrony among children in schools for the deaf. | 4.35e-06 | 2 | 73 | 2 | 16222667 | |
| Pubmed | [Influence of Cx26/Cx32 gap junction channel on antineoplastic effect of etoposide in Hela cells]. | 4.35e-06 | 2 | 73 | 2 | 22445976 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26490746 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 20022641 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19887791 | ||
| Pubmed | Hearing impairment in Dutch patients with connexin 26 (GJB2) and connexin 30 (GJB6) mutations. | 4.35e-06 | 2 | 73 | 2 | 15656949 | |
| Pubmed | The association between GJB2 mutation and GJB6 gene in non syndromic hearing loss school children. | 4.35e-06 | 2 | 73 | 2 | 22106692 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16381801 | ||
| Pubmed | GJB2 and GJB6 Genetic Variant Curation in an Argentinean Non-Syndromic Hearing-Impaired Cohort. | 4.35e-06 | 2 | 73 | 2 | 33096615 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 20442751 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19844737 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17368814 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26265468 | ||
| Pubmed | Structural studies of N-terminal mutants of Connexin 26 and Connexin 32 using (1)H NMR spectroscopy. | 4.35e-06 | 2 | 73 | 2 | 27378082 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25288386 | ||
| Pubmed | GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review. | 4.35e-06 | 2 | 73 | 2 | 12172392 | |
| Pubmed | Prevalence of DFNB1 mutations in Slovak patients with non-syndromic hearing loss. | 4.35e-06 | 2 | 73 | 2 | 22281373 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24774219 | ||
| Pubmed | Novel exon 1 protein-coding regions N-terminally extend human KCNE3 and KCNE4. | 4.35e-06 | 2 | 73 | 2 | 27162025 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 20381175 | ||
| Pubmed | Infant hearing loss and connexin testing in a diverse population. | 4.35e-06 | 2 | 73 | 2 | 18580690 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 31200317 | ||
| Pubmed | Connexin channels and phospholipids: association and modulation. | 4.35e-06 | 2 | 73 | 2 | 19686581 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 10805080 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 14759569 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 20563649 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15638823 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17695503 | ||
| Pubmed | Phenotype/genotype correlations in a DFNB1 cohort with ethnical diversity. | 4.35e-06 | 2 | 73 | 2 | 18758381 | |
| Pubmed | Performance of speech perception after cochlear implantation in DFNB1 patients. | 4.35e-06 | 2 | 73 | 2 | 19051073 | |
| Pubmed | GJB2 and GJB6 gene mutations found in Indian probands with congenital hearing impairment. | 4.35e-06 | 2 | 73 | 2 | 20086291 | |
| Pubmed | Non-syndromic hearing impairment in a multi-ethnic population of Northeastern Brazil. | 4.35e-06 | 2 | 73 | 2 | 23684175 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11668644 | ||
| Pubmed | Pediatric cholesteatoma and variants in the gene encoding connexin 26. | 4.35e-06 | 2 | 73 | 2 | 19877196 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18294049 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19173109 | ||
| Pubmed | Prevalence of GJB2 mutations and the del(GJB6-D13S1830) in Argentinean non-syndromic deaf patients. | 4.35e-06 | 2 | 73 | 2 | 15964725 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19715470 | ||
| Pubmed | Ca2+-dependent regulation of sodium channels NaV1.4 and NaV1.5 is controlled by the post-IQ motif. | 4.35e-06 | 2 | 73 | 2 | 30944319 | |
| Pubmed | Connexins 26 and 30 are co-assembled to form gap junctions in the cochlea of mice. | 4.35e-06 | 2 | 73 | 2 | 12859965 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12865758 | ||
| Pubmed | Human cell responses to ionizing radiation are differentially affected by the expressed connexins. | 4.35e-06 | 2 | 73 | 2 | 23139176 | |
| Pubmed | Genotyping for Cx26 and Cx30 mutations in cases with congenital hearing loss. | 4.35e-06 | 2 | 73 | 2 | 18554165 | |
| Pubmed | Connexin gene mutations among Ugandan patients with nonsyndromic sensorineural hearing loss. | 4.35e-06 | 2 | 73 | 2 | 24706568 | |
| Pubmed | GJB2 and GJB6 mutations in 165 Danish patients showing non-syndromic hearing impairment. | 4.35e-06 | 2 | 73 | 2 | 15345117 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22292956 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 30202070 | ||
| Pubmed | Connexin 26 and 30 genes mutations in patients with chronic rhinosinusitis. | 4.35e-06 | 2 | 73 | 2 | 17989577 | |
| Pubmed | GJB2 and GJB6 screening in Tunisian patients with autosomal recessive deafness. | 4.35e-06 | 2 | 73 | 2 | 23434199 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22704424 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19465004 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 28779115 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15464308 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15464305 | ||
| Pubmed | Connexin 26 and connexin 30 mutations in children with nonsyndromic hearing loss. | 4.35e-06 | 2 | 73 | 2 | 15064611 | |
| Pubmed | Analysis of the presence of the GJB6 mutations in patients heterozygous for GJB2 mutation in Brazil. | 4.35e-06 | 2 | 73 | 2 | 23553242 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 28077706 | ||
| Pubmed | Expressions of connexin 32 and 26 and their correlation to prognosis of non-small cell lung cancer. | 4.35e-06 | 2 | 73 | 2 | 19550132 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11834499 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17227867 | ||
| Pubmed | A large deletion including most of GJB6 in recessive non syndromic deafness: a digenic effect? | 4.35e-06 | 2 | 73 | 2 | 11896458 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23171692 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23863883 | ||
| Pubmed | Etiology of unilateral hearing loss in a national hereditary deafness repository. | 4.35e-06 | 2 | 73 | 2 | 22534022 | |
| Pubmed | Human connexin26 and connexin30 form functional heteromeric and heterotypic channels. | 4.35e-06 | 2 | 73 | 2 | 17615163 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 20233142 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19371219 | ||
| Pubmed | Nonsyndromic Hearing Loss and Deafness, DFNA3 – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 4.35e-06 | 2 | 73 | 2 | 20301708 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16217030 | ||
| Pubmed | Regulation of human cardiac potassium channels by full-length KCNE3 and KCNE4. | 4.35e-06 | 2 | 73 | 2 | 27922120 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26232528 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19047647 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17666888 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26075227 | ||
| Pubmed | Expression of GJB2 and GJB6 is reduced in a novel DFNB1 allele. | 4.35e-06 | 2 | 73 | 2 | 16773579 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 20835527 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21287563 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 23687377 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21478159 | ||
| Cytoband | 9q31.1 | 3.78e-05 | 41 | 72 | 3 | 9q31.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 6.67e-05 | 137 | 72 | 4 | chr9q31 | |
| Cytoband | 11q24.1 | 1.56e-03 | 37 | 72 | 2 | 11q24.1 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.73e-06 | 9 | 59 | 3 | 1203 | |
| GeneFamily | Gap junction proteins | 4.86e-05 | 22 | 59 | 3 | 314 | |
| GeneFamily | Olfactory receptors, family 13 | 5.58e-05 | 23 | 59 | 3 | 162 | |
| GeneFamily | Purinergic receptors P2Y | 4.63e-04 | 10 | 59 | 2 | 213 | |
| GeneFamily | ATP binding cassette subfamily A | 9.29e-04 | 14 | 59 | 2 | 805 | |
| GeneFamily | Potassium voltage-gated channel regulatory subunits|DASH family | 1.07e-03 | 15 | 59 | 2 | 858 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 1.73e-03 | 19 | 59 | 2 | 563 | |
| GeneFamily | Solute carriers | 1.78e-03 | 395 | 59 | 6 | 752 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.24e-03 | 26 | 59 | 2 | 253 | |
| GeneFamily | Transient receptor potential cation channels | 3.75e-03 | 28 | 59 | 2 | 249 | |
| GeneFamily | Olfactory receptors, family 6 | 1.20e-02 | 51 | 59 | 2 | 153 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 5.08e-06 | 166 | 69 | 6 | M39026 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.66e-07 | 91 | 62 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_1000 | |
| CoexpressionAtlas | BM Top 100 - cerebellum | 4.66e-05 | 68 | 62 | 4 | BM Top 100 - cerebellum | |
| CoexpressionAtlas | cerebral cortex | GABRB2 SEMA6B CACNA1A GPM6B CACNA1E GPR21 P2RY12 KCND2 GJB6 SCN2A DISP2 GRIK4 ADCY2 MMD2 | 4.97e-05 | 1428 | 62 | 14 | cerebral cortex |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_200 | 1.59e-04 | 175 | 62 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_200 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 1.85e-04 | 409 | 62 | 7 | GSM605840_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2 | 1.87e-04 | 410 | 62 | 7 | GSM854297_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 1.93e-04 | 412 | 62 | 7 | GSM605843_500 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3 | 2.02e-04 | 415 | 62 | 7 | GSM854299_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_500 | 2.33e-04 | 41 | 62 | 3 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 2.64e-04 | 734 | 62 | 9 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.66e-08 | 198 | 73 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-07 | 176 | 73 | 6 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-07 | 176 | 73 | 6 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-07 | 180 | 73 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-07 | 180 | 73 | 6 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-07 | 180 | 73 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.97e-07 | 198 | 73 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.22e-06 | 128 | 73 | 5 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.40e-06 | 159 | 73 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.60e-06 | 160 | 73 | 5 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.60e-06 | 160 | 73 | 5 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-pDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.89e-06 | 166 | 73 | 5 | 9fa90d9d484563d44738bb2c6eb0775dffc4d549 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-06 | 167 | 73 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | TCGA-Brain|World / Sample_Type by Project: Shred V9 | 8.86e-06 | 170 | 73 | 5 | f78e360a6a44d599ec0d207cba4704e50aa314f8 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 171 | 73 | 5 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-06 | 171 | 73 | 5 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.12e-06 | 171 | 73 | 5 | b2e753e811a7639956994609f73efcdb62d04f82 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.92e-06 | 174 | 73 | 5 | c9d4e375dedd2b099a9ed70ec38ff35bbb0ce48a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.92e-06 | 174 | 73 | 5 | 1463c98f8f519dd030587abbdbeb1b4e1bca5dd1 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.92e-06 | 174 | 73 | 5 | d421c0069d24cb560a3a429929e3cd1eceaeabcf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 175 | 73 | 5 | 787ac1a12cda10af5c8830471702a4cbaf43e79e | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 1.08e-05 | 177 | 73 | 5 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | wk_15-18-Hematologic-Myeloid-Myelocyte-like|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 185 | 73 | 5 | 92b9ec18ff7c53a52b87e2c2012d0b719a7ad20a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 185 | 73 | 5 | 872720275789d249c9859de825a923803d458875 | |
| ToppCell | normal-na-Myeloid-plasmacytoid_dendritic_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.33e-05 | 185 | 73 | 5 | 3091870a5bf8ecb963e560b47c8502bae367416c | |
| ToppCell | Mild-Lymphoid-pDC|Mild / Condition, Lineage, Cell class and cell subclass | 1.37e-05 | 186 | 73 | 5 | 7fa82972c726025d6402e5eb7bf0db3b699eba4c | |
| ToppCell | Mild-Lymphoid-pDC-|Mild / Condition, Lineage, Cell class and cell subclass | 1.37e-05 | 186 | 73 | 5 | 1d05e73ae2ec0cc27f79e4fa40d6b21790059f80 | |
| ToppCell | Mild_COVID-19-Myeloid-pDC|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.40e-05 | 187 | 73 | 5 | 99c3c4a7b9179dce7982dc6516d561c952abc80e | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-pDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.40e-05 | 187 | 73 | 5 | bf64a6ef5062ec9a0f7095e8c97ce66bfc3bf179 | |
| ToppCell | control-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.40e-05 | 187 | 73 | 5 | c78aee98b32719aa45811b620fc97be1ecf5fd53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 189 | 73 | 5 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 1.56e-05 | 191 | 73 | 5 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-pDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-05 | 191 | 73 | 5 | faf4de97003a938a243b0101456913c2b0e1804f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.63e-05 | 193 | 73 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | control-pDC|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.63e-05 | 193 | 73 | 5 | 30a6559c9a9e8941861cb259b4836acccc427e68 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-pDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.63e-05 | 193 | 73 | 5 | 2a48e72f3df2ad64e1680fca759be8fd2190771e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.68e-05 | 194 | 73 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.68e-05 | 194 | 73 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.72e-05 | 195 | 73 | 5 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.72e-05 | 195 | 73 | 5 | 702dc7397c4a3ee50bb97ca24b9ab0d9b07fec9b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 196 | 73 | 5 | b07db4a53ab9be9aad6fae5e45f9547db829d096 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.76e-05 | 196 | 73 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.76e-05 | 196 | 73 | 5 | 77feb22fd0b0b1df03375da472134412e9e69c90 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 196 | 73 | 5 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.76e-05 | 196 | 73 | 5 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.80e-05 | 197 | 73 | 5 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.80e-05 | 197 | 73 | 5 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 197 | 73 | 5 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.80e-05 | 197 | 73 | 5 | 54fb207638e211f8efdb13003ae62a6b1f003b09 | |
| ToppCell | distal-Epithelial-Basal-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.80e-05 | 197 | 73 | 5 | 75b4292ce2ad7f9c8b6a4781e1cb71f5b18b74e3 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-05 | 198 | 73 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.85e-05 | 198 | 73 | 5 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 1.89e-05 | 199 | 73 | 5 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | Caecum-(7)_Mast_cell|Caecum / shred on region, Cell_type, and subtype | 1.94e-05 | 200 | 73 | 5 | d23fe8644ce42ace51fcde43cb4cd22a99300c02 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 200 | 73 | 5 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Caecum-Mast_cell|Caecum / Region, Cell class and subclass | 1.94e-05 | 200 | 73 | 5 | 8791d0b3d883e7a747a23d21118817f5be4013b6 | |
| ToppCell | Caecum-(7)_Mast_cell-(70)_Mast|Caecum / shred on region, Cell_type, and subtype | 1.94e-05 | 200 | 73 | 5 | 9974285c28a633a010c4f24d035ad3685705e881 | |
| ToppCell | Caecum-Mast_cell-Mast|Caecum / Region, Cell class and subclass | 1.94e-05 | 200 | 73 | 5 | 168426e8296697d05684d71989c4eb5bb2a0489f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.67e-05 | 127 | 73 | 4 | fbf7e6bea9991628e98f75c279e2992031dcb8db | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.83e-05 | 138 | 73 | 4 | 8d70e64843f7c3be8ee4203cc126fdf1001f0df5 | |
| ToppCell | TCGA-Thryoid|World / Sample_Type by Project: Shred V9 | 7.83e-05 | 138 | 73 | 4 | 8cbae2ec9a51712bed5b4e5f9f834ecccb6b7a47 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-05 | 142 | 73 | 4 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 148 | 73 | 4 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 150 | 73 | 4 | ee2da4f684add821f2653d5db8eef46cd95c0fda | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 152 | 73 | 4 | ebce79e106bf1d84241f8dd3496ff1771f9666be | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 152 | 73 | 4 | 4a749d1b6d35fd55a8c42d7bd04b6ff5b11ce781 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 154 | 73 | 4 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 154 | 73 | 4 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 154 | 73 | 4 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 154 | 73 | 4 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | Goblet|World / Class top | 1.29e-04 | 157 | 73 | 4 | b352aa37d662629db6a9c6def9ee6d7c49a9071c | |
| ToppCell | Goblet-gob-1|World / Class top | 1.35e-04 | 159 | 73 | 4 | 62d4ca2b538382419252e306d7a789b64420fb18 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-9|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.35e-04 | 159 | 73 | 4 | f376bf6cd0ed374211edac3c384f3a78f0caef2a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.49e-04 | 163 | 73 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 166 | 73 | 4 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 166 | 73 | 4 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 166 | 73 | 4 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 166 | 73 | 4 | d1c61270c7b39bb365020eeafe298a8f88aa887e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 166 | 73 | 4 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.67e-04 | 168 | 73 | 4 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.67e-04 | 168 | 73 | 4 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 169 | 73 | 4 | b2fdf9f842dc7c181bc951a8a6932c916ed835ef | |
| ToppCell | COVID-19-Heart-Adipocyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 169 | 73 | 4 | bd39f85b48207955f80ca120a11e15a0124117b9 | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 169 | 73 | 4 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-04 | 169 | 73 | 4 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-04 | 169 | 73 | 4 | 2322f03a115c662f808ebfc892192b7d38d48181 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.75e-04 | 170 | 73 | 4 | 98d13dbd76a826e47d55553f9d11f71c043b573e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-04 | 171 | 73 | 4 | 3ef44a5e3e8f81424f1e9aa302860b6688a549b8 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.79e-04 | 171 | 73 | 4 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.79e-04 | 171 | 73 | 4 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-04 | 171 | 73 | 4 | 3a2fefcb62e9d47ae6b3a946c45d3f2dd32c576c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 171 | 73 | 4 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | COVID-pDC|COVID / Condition, Cell_class and T cell subcluster | 1.83e-04 | 172 | 73 | 4 | 3ecbb000495dde32f6153ef6bdea9c8802ff3985 | |
| ToppCell | COVID-pDC-|COVID / Condition, Cell_class and T cell subcluster | 1.83e-04 | 172 | 73 | 4 | a7827faa1afab51fdaf0cb1a2babcd2e00d411e5 | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.87e-04 | 173 | 73 | 4 | e1de849dcd96063136bdac87e050ddbd55cabdcc | |
| ToppCell | Bronchial_Brush-Epithelial-Ionocytes|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.87e-04 | 173 | 73 | 4 | f2a8f4918c1fb68d98bc3f33cd624de0f0f11e06 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-pDC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.87e-04 | 173 | 73 | 4 | b571970e3ba88afc07041c5692ccfd85fc39e796 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-04 | 174 | 73 | 4 | 42735f6a8e5ec36dd3d35aceea6d37cf3eaa1871 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.95e-04 | 175 | 73 | 4 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.95e-04 | 175 | 73 | 4 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| Drug | gabapentin | GABRB2 CACNA1A GABRG3 CACNA1E SCN4A SCN5A SCN7A GRIK4 RYR3 ITPR1 | 1.21e-10 | 169 | 71 | 10 | CID000003446 |
| Drug | potassium | GABRB2 CACNA1A GABRG3 CACNA1E GJB2 KCNE4 KCNE3 TRPM5 CLCN5 KCND2 SCN2A SCN4A SCN5A SCN7A SLC12A8 GRIK4 ADCY2 RYR3 ITPR1 | 1.56e-10 | 1008 | 71 | 19 | CID000000813 |
| Drug | riluzole | GABRB2 CACNA1A GABRG3 CACNA1E SCN4A SCN5A SCN7A GRIK4 RYR3 ITPR1 | 1.62e-10 | 174 | 71 | 10 | CID000005070 |
| Drug | pyraclofos | 1.41e-09 | 106 | 71 | 8 | CID000093460 | |
| Drug | lamotrigine | 2.90e-09 | 116 | 71 | 8 | CID000003878 | |
| Drug | verapamil | CACNA1A CACNA1E KCNE4 KCNE3 KCND2 ABCA13 SCN4A SCN5A SCN7A ADCY2 ABCA8 RYR3 ITPR1 | 3.38e-09 | 490 | 71 | 13 | CID000002520 |
| Drug | heptanol | 3.56e-09 | 42 | 71 | 6 | CID000008129 | |
| Drug | NSC7524 | 5.31e-09 | 182 | 71 | 9 | CID000005657 | |
| Drug | tetradotoxin | GABRB2 CACNA1A GABRG3 CACNA1E P2RY12 KCND2 SCN2A SCN4A SCN5A SCN7A P2RY14 GRIK4 | 7.86e-09 | 428 | 71 | 12 | CID000020382 |
| Drug | sodium | GABRB2 GABRG3 KCNE3 ATP6V0D1 TRPM5 KCND2 SLC26A2 SCN2A SCN4A SCN5A SCN7A SLC12A8 GRIK4 PRPF8 ADCY2 RYR3 | 2.53e-08 | 944 | 71 | 16 | CID000000923 |
| Drug | procaine | 2.57e-08 | 153 | 71 | 8 | CID000004914 | |
| Drug | Fospropofol | 1.16e-07 | 4 | 71 | 3 | DB06716 | |
| Drug | Propofol | 1.16e-07 | 4 | 71 | 3 | DB00818 | |
| Drug | bepridil | 1.33e-07 | 126 | 71 | 7 | CID000002351 | |
| Drug | QX-314 | 2.15e-07 | 82 | 71 | 6 | CID000003925 | |
| Drug | lanthanum | 2.25e-07 | 136 | 71 | 7 | CID000023926 | |
| Drug | phenytoin | 4.08e-07 | 219 | 71 | 8 | CID000001775 | |
| Drug | lidocaine | 6.77e-07 | 160 | 71 | 7 | CID000003676 | |
| Drug | isradipine | 7.01e-07 | 100 | 71 | 6 | CID000003784 | |
| Drug | methanethiosulfonate | 8.35e-07 | 103 | 71 | 6 | CID004188587 | |
| Drug | fluorocyclobutane | 1.01e-06 | 7 | 71 | 3 | CID011051569 | |
| Drug | baclofen | 2.21e-06 | 191 | 71 | 7 | CID000002284 | |
| Drug | tocainide | 2.24e-06 | 30 | 71 | 4 | CID000038945 | |
| Drug | flecainide | 2.84e-06 | 71 | 71 | 5 | CID000003355 | |
| Drug | 3-aminopropylphosphinic acid | 2.92e-06 | 32 | 71 | 4 | CID006335948 | |
| Drug | CNS 1145 | 3.32e-06 | 33 | 71 | 4 | CID000190902 | |
| Drug | IHC-64 | 3.32e-06 | 33 | 71 | 4 | CID000162753 | |
| Drug | ethosuximide | 3.48e-06 | 74 | 71 | 5 | CID000003291 | |
| Drug | nimodipine | 6.13e-06 | 145 | 71 | 6 | CID000004497 | |
| Drug | 18b-glycyrrhetic acid | 6.14e-06 | 83 | 71 | 5 | CID000003230 | |
| Drug | KN-62 | 7.52e-06 | 230 | 71 | 7 | CID000003838 | |
| Drug | glutamate | GABRB2 CACNA1A GABRG3 CACNA1E TRPM5 CLCN5 KCND2 SCN4A TAS1R2 GRIK4 ADCY2 RYR3 ITPR1 | 7.53e-06 | 962 | 71 | 13 | CID000000611 |
| Drug | DB08666 | 9.14e-06 | 90 | 71 | 5 | CID011840988 | |
| Drug | mu-conotoxin KIIIA, Conus kinoshitai | 9.59e-06 | 2 | 71 | 2 | ctd:C502265 | |
| Drug | Flecainide | 9.59e-06 | 2 | 71 | 2 | DB01195 | |
| Drug | butamben | 1.29e-05 | 15 | 71 | 3 | CID000002482 | |
| Drug | nitrendipine | 1.39e-05 | 98 | 71 | 5 | CID000004507 | |
| Drug | chloride | GABRB2 GABRG3 SLC46A2 KCNE3 CLCN5 SLC26A2 SCN2A SCN4A PKD2L1 SLC12A8 PRPF8 ADCY2 ITPR1 | 1.54e-05 | 1029 | 71 | 13 | CID000000312 |
| Drug | 4-AP | 1.59e-05 | 258 | 71 | 7 | CID000001727 | |
| Drug | gamma-aminobutyric acid | 1.62e-05 | 474 | 71 | 9 | CID000000119 | |
| Drug | V ms | 1.65e-05 | 49 | 71 | 4 | CID005289556 | |
| Drug | Zonisamide | 1.92e-05 | 17 | 71 | 3 | DB00909 | |
| Drug | AC1L1F6H | 2.03e-05 | 106 | 71 | 5 | CID000003104 | |
| Drug | strychnine HCl | 2.17e-05 | 181 | 71 | 6 | CID000005304 | |
| Drug | abecarnil | 2.29e-05 | 18 | 71 | 3 | CID000065914 | |
| Drug | valproate | 2.42e-05 | 381 | 71 | 8 | CID000003121 | |
| Drug | N6-Me-dAdo | 2.72e-05 | 19 | 71 | 3 | CID000168948 | |
| Drug | Cinildipine | 2.82e-05 | 56 | 71 | 4 | CID000002752 | |
| Drug | 5-deoxy-5-fluoro-myo-inositol | 2.87e-05 | 3 | 71 | 2 | CID000195110 | |
| Drug | U46619 | 3.00e-05 | 285 | 71 | 7 | CID000005618 | |
| Drug | dihydropyridine | 3.11e-05 | 193 | 71 | 6 | CID000104822 | |
| Drug | aldosterone | 3.25e-05 | 397 | 71 | 8 | CID000005839 | |
| Drug | gadolinium | 3.69e-05 | 199 | 71 | 6 | CID000023982 | |
| Drug | valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.69e-05 | 199 | 71 | 6 | 5906_DN | |
| Drug | AC1L1BIT | 3.71e-05 | 60 | 71 | 4 | CID000001457 | |
| Drug | nilvadipine | 3.71e-05 | 60 | 71 | 4 | CID000004494 | |
| Drug | Cascade Blue | 3.71e-05 | 21 | 71 | 3 | CID000014886 | |
| Drug | IAA-94 | 3.96e-05 | 61 | 71 | 4 | CID000003667 | |
| Drug | lercanidipine | 4.50e-05 | 63 | 71 | 4 | CID000065866 | |
| Drug | disopyramide | 5.41e-05 | 66 | 71 | 4 | CID000003114 | |
| Drug | halothane | 5.54e-05 | 314 | 71 | 7 | CID000003562 | |
| Drug | AC 110 | 5.73e-05 | 4 | 71 | 2 | CID000022860 | |
| Drug | gallopamil | 5.74e-05 | 67 | 71 | 4 | CID000001234 | |
| Drug | CCD 1042 | 6.36e-05 | 25 | 71 | 3 | CID000038022 | |
| Drug | forskolin from Coleus forskohlii | GABRB2 GABRG3 KCNE3 ATP6V0D1 P2RY12 KCND2 SCN4A SCN7A P2RY14 ADCY2 RYR3 ITPR1 | 6.38e-05 | 1013 | 71 | 12 | CID000003413 |
| Drug | AC1L2AC7 | 6.44e-05 | 69 | 71 | 4 | CID000068733 | |
| Drug | felbamate | 6.81e-05 | 70 | 71 | 4 | CID000003331 | |
| Drug | CAS 298-57-7 | 8.03e-05 | 73 | 71 | 4 | CID000002761 | |
| Drug | PbTx-1 | 8.06e-05 | 27 | 71 | 3 | CID006437089 | |
| Drug | AC1L1MOZ | 8.06e-05 | 27 | 71 | 3 | CID000031958 | |
| Drug | 3-(1H-pyrrole-2-carboxylate | 8.85e-05 | 233 | 71 | 6 | CID000005114 | |
| Drug | N-ethyl-N-(4-hydroxybutyl)nitrosamine | 9.53e-05 | 5 | 71 | 2 | CID000041223 | |
| Drug | caged InsP3 | 1.00e-04 | 29 | 71 | 3 | CID000122248 | |
| Drug | nisoldipine | 1.04e-04 | 78 | 71 | 4 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.09e-04 | 79 | 71 | 4 | CID005287890 | |
| Drug | oxcarbazepine | 1.11e-04 | 30 | 71 | 3 | CID000034312 | |
| Drug | lindane | 1.21e-04 | 154 | 71 | 5 | CID000000727 | |
| Drug | APETx1, Anthopleura elegantissima | 1.43e-04 | 6 | 71 | 2 | ctd:C475726 | |
| Drug | 3,4-dihydroquinazoline | 1.43e-04 | 6 | 71 | 2 | CID000583065 | |
| Drug | 2,6-xylenol | 1.43e-04 | 6 | 71 | 2 | ctd:C036531 | |
| Drug | alpha-sialylcholesterol | 1.43e-04 | 6 | 71 | 2 | CID000133976 | |
| Drug | acetyl-leucyl-glutamyl-histidyl-aspartal | 1.43e-04 | 6 | 71 | 2 | ctd:C420218 | |
| Drug | amiodarone | 1.44e-04 | 160 | 71 | 5 | CID000002156 | |
| Drug | AC1L2FYN | 1.48e-04 | 33 | 71 | 3 | CID000071333 | |
| Drug | IPSP | 1.59e-04 | 87 | 71 | 4 | CID000022083 | |
| Drug | desethylamiodarone | 1.62e-04 | 34 | 71 | 3 | CID000104774 | |
| Drug | NSC15627 | 1.62e-04 | 34 | 71 | 3 | CID000002073 | |
| Drug | NBQX | 1.81e-04 | 90 | 71 | 4 | CID003272523 | |
| Drug | 2-amino-4-phosphonobutyric acid | 1.89e-04 | 91 | 71 | 4 | CID000002207 | |
| Drug | N-methyl-DL-aspartic acid | 1.94e-04 | 655 | 71 | 9 | CID000004376 | |
| Drug | APMPA | 1.99e-04 | 7 | 71 | 2 | CID000512300 | |
| Drug | Br2BAPTA | 1.99e-04 | 7 | 71 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.99e-04 | 7 | 71 | 2 | CID009547999 | |
| Drug | benzocaine | 2.09e-04 | 37 | 71 | 3 | CID000002337 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 2.09e-04 | 37 | 71 | 3 | CID000009643 | |
| Drug | sipatrigine | 2.09e-04 | 37 | 71 | 3 | CID000060803 | |
| Drug | 4-chloro-m-cresol | 2.09e-04 | 37 | 71 | 3 | CID000001732 | |
| Drug | cobalt-60 | 2.13e-04 | 390 | 71 | 7 | CID000061492 | |
| Drug | manidipine | 2.23e-04 | 95 | 71 | 4 | CID000004008 | |
| Drug | isoproterenol | 2.27e-04 | 669 | 71 | 9 | CID000003779 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 1.26e-08 | 12 | 68 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 1.01e-07 | 163 | 68 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 2.49e-06 | 93 | 68 | 5 | C1535926 | |
| Disease | Keratitis-Ichthyosis-Deafness Syndrome | 5.23e-06 | 2 | 68 | 2 | C3665333 | |
| Disease | Senter syndrome | 5.23e-06 | 2 | 68 | 2 | C0265336 | |
| Disease | autosomal recessive nonsyndromic deafness 1A (implicated_via_orthology) | 5.23e-06 | 2 | 68 | 2 | DOID:0110475 (implicated_via_orthology) | |
| Disease | DFNA 3 Nonsyndromic Hearing Loss and Deafness | 5.23e-06 | 2 | 68 | 2 | cv:CN043589 | |
| Disease | autosomal recessive nonsyndromic deafness 1A (is_implicated_in) | 5.23e-06 | 2 | 68 | 2 | DOID:0110475 (is_implicated_in) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 1A | 1.57e-05 | 3 | 68 | 2 | 220290 | |
| Disease | DEAFNESS, X-LINKED 2 | 1.57e-05 | 3 | 68 | 2 | 304400 | |
| Disease | Deafness, autosomal dominant nonsyndromic sensorineural 3 | 1.57e-05 | 3 | 68 | 2 | cv: | |
| Disease | Progressive hearing loss stapes fixation | 1.57e-05 | 3 | 68 | 2 | C1844678 | |
| Disease | Hyperkalemic periodic paralysis | 1.57e-05 | 3 | 68 | 2 | C0238357 | |
| Disease | DEAFNESS, DIGENIC, GJB2/GJB6 (disorder) | 1.57e-05 | 3 | 68 | 2 | C2673760 | |
| Disease | DEAFNESS, DIGENIC, GJB2/GJB3 (disorder) | 1.57e-05 | 3 | 68 | 2 | C2673761 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 1A (disorder) | 1.57e-05 | 3 | 68 | 2 | C2673759 | |
| Disease | X-linked mixed hearing loss with perilymphatic gusher | 1.57e-05 | 3 | 68 | 2 | cv:C1844678 | |
| Disease | Autosomal recessive nonsyndromic hearing loss 1A | 1.57e-05 | 3 | 68 | 2 | cv:C2673759 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.57e-05 | 3 | 68 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 3.13e-05 | 4 | 68 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | autoimmune thyroiditis (biomarker_via_orthology) | 3.13e-05 | 4 | 68 | 2 | DOID:7188 (biomarker_via_orthology) | |
| Disease | Hypokalemic periodic paralysis | 3.13e-05 | 4 | 68 | 2 | C0238358 | |
| Disease | Hidrotic Ectodermal Dysplasia | 5.21e-05 | 5 | 68 | 2 | C0162361 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.09e-04 | 7 | 68 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | 1.14e-04 | 477 | 68 | 7 | C0005586 | |
| Disease | Brugada syndrome | 1.45e-04 | 8 | 68 | 2 | cv:C1142166 | |
| Disease | Scoliosis, unspecified | 1.45e-04 | 8 | 68 | 2 | C0036439 | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 2.33e-04 | 10 | 68 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | middle temporal gyrus volume measurement | 2.84e-04 | 11 | 68 | 2 | EFO_0010316 | |
| Disease | Long QT Syndrome | 2.84e-04 | 11 | 68 | 2 | C0023976 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 4.82e-04 | 157 | 68 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | coronary artery calcification | 5.99e-04 | 450 | 68 | 6 | EFO_0004723 | |
| Disease | Tremor, Rubral | 6.15e-04 | 16 | 68 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 6.15e-04 | 16 | 68 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 6.15e-04 | 16 | 68 | 2 | C0278161 | |
| Disease | Ataxia, Sensory | 6.15e-04 | 16 | 68 | 2 | C0240991 | |
| Disease | Abnormal coordination | 6.15e-04 | 16 | 68 | 2 | C0520966 | |
| Disease | Ataxia, Truncal | 6.15e-04 | 16 | 68 | 2 | C0427190 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 6.96e-04 | 17 | 68 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | Depression, Bipolar | 8.17e-04 | 79 | 68 | 3 | C0005587 | |
| Disease | progression free survival, ovarian serous carcinoma | 1.17e-03 | 22 | 68 | 2 | EFO_0004920, EFO_1001516 | |
| Disease | Brugada Syndrome (disorder) | 1.40e-03 | 24 | 68 | 2 | C1142166 | |
| Disease | Ataxia | 1.52e-03 | 25 | 68 | 2 | C0004134 | |
| Disease | obesity (implicated_via_orthology) | 1.55e-03 | 215 | 68 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 2.04e-03 | 29 | 68 | 2 | cv:C5779548 | |
| Disease | Epilepsy | 2.06e-03 | 109 | 68 | 3 | C0014544 | |
| Disease | Epileptic encephalopathy | 2.18e-03 | 30 | 68 | 2 | C0543888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFLYYAEFIFLGLFM | 516 | O00555 | |
| MSIFYVVYFVVFPFF | 1486 | O00555 | |
| AFVSVYIQEMFRFAY | 76 | Q8WW43 | |
| RMEMSIFYVVYFVVF | 1396 | Q15878 | |
| FTNFLYDMLFYLVSV | 4501 | Q86UQ4 | |
| FYDFFRYVEMSTFDI | 166 | Q9Y376 | |
| FFRVIFEAAFMYVFY | 141 | P29033 | |
| YARIVFAIISFYFMP | 16 | O14735 | |
| SLYYVAFYVVMTGLF | 41 | P51164 | |
| VAFFLYQVAFRMAYF | 526 | A7MBM2 | |
| TVVIIFYGTIFFMYA | 246 | Q8NGS5 | |
| FDRMVIYFFIAASYA | 106 | Q8IY49 | |
| EYFYILVVMSFYGIF | 86 | Q8WWG9 | |
| FMYVAAAAFVLLFFV | 1736 | P46531 | |
| VAIMAVDIFFHFFYI | 256 | Q9HCP6 | |
| MVFFAYFIVTRQDYT | 261 | Q9NWR8 | |
| VFYIQYLKSMAFSVY | 1741 | Q71F56 | |
| FAARVIYDLLFFFMV | 2571 | Q14643 | |
| NSYMYILFVMFLFAV | 56 | Q9Y6H6 | |
| STMALVFYYVTGFFI | 181 | Q9NZV8 | |
| LVGMVYVFYFASFIL | 426 | O60337 | |
| VFMALLEYALVNYIF | 316 | P47870 | |
| VVSLFYGTLFFMYVQ | 251 | Q8NGQ2 | |
| LTVVIVFYGTLFFMY | 246 | Q9NQN1 | |
| VAVVSLFYGSIIFMY | 246 | Q8N628 | |
| SVIFYFTMYISISFL | 101 | Q9H244 | |
| MIQTYFYFFLGTVEF | 96 | Q8NGM8 | |
| LMQYVIYGIASFFFL | 86 | Q13491 | |
| YFVSMYGSVFTICFI | 101 | Q9Y2T6 | |
| YLFHFLIDYAELVFM | 71 | Q9H490 | |
| ALYYFTFVDVMEFKD | 91 | Q9Y2A7 | |
| VFTVVISYAIMFLYI | 621 | O15118 | |
| QVSFFLFIIFVVYTM | 136 | Q08462 | |
| FVFAALMEYATLNYY | 326 | Q99928 | |
| GYRVIFYIMVDAFFK | 106 | Q7Z4J2 | |
| FFRIIFEAAFMYVFY | 141 | O95452 | |
| EGAFAYIVNYFMYVL | 201 | P51795 | |
| LIAFAQYIAEDYFMA | 226 | Q16739 | |
| FRLLFEAVFMYVFYL | 141 | P08034 | |
| MVSAYYTYIFTNLEF | 236 | Q16099 | |
| YFIQTMAYADLFVGV | 66 | Q99679 | |
| FMLTYVAVDYSYFSL | 391 | A0AV02 | |
| YTLVNMGVAAIVYFY | 616 | A0AV02 | |
| LYGFIFYMFHVELTE | 396 | Q5SR56 | |
| VFFTVFSAVYFMTVV | 26 | Q8NGN0 | |
| TVVIIFYGTIFFMYA | 276 | Q8NGS6 | |
| PYQKIVLFFMFLFVY | 21 | P0C626 | |
| TVVIIFYGTIFFMYA | 246 | Q8NGS7 | |
| FFVLSYGQEVLIYSM | 726 | A6NKG5 | |
| IIAFCEMFSVVYVYG | 496 | Q695T7 | |
| MYLYFVIFIIFGSFF | 1271 | P35499 | |
| FVVILYLIYASFSFM | 466 | Q6ZW05 | |
| MYIYFVIFIIFGSFF | 1446 | Q14524 | |
| FYVNMYVSIVFFGLI | 101 | Q15391 | |
| FVFIYLMSYISNFED | 1081 | O94911 | |
| FASFIVQYYGLVMDL | 1036 | Q6P2Q9 | |
| VYFFFREIAMEFNYL | 241 | Q9H3T3 | |
| MYFAFLFLFTYVLLV | 741 | Q9NZQ8 | |
| AKDVAVSFYYFFLMV | 131 | P49888 | |
| NLLFYSVYEAMAFAE | 706 | P50443 | |
| IMYLFTFLAATIAYF | 191 | Q8N7C7 | |
| PYEMYRIVFDITFFF | 4741 | Q15413 | |
| YMIFFVLVIFLGSFY | 401 | Q99250 | |
| FVTYVFFVFFVLLNM | 541 | Q9P0L9 | |
| YNEAKFITLSMTFYF | 756 | Q8TE23 | |
| YFILMFIVYAFEVAS | 91 | O75841 | |
| TVIFFVMILDFYVDS | 276 | Q8TAD4 | |
| AFVKETYMFYIARAV | 366 | Q9BY10 | |
| MIFFVVVSFLFSFYM | 371 | Q01118 | |
| LCFSMVYMTFYIVEF | 256 | Q5TAH2 | |
| IFFFFLYYISSILMT | 241 | Q9NYW2 | |
| FLDFITYSYMIDNVI | 96 | P61421 | |
| SFQEFFAAMYYILDE | 516 | P59046 | |
| FMDDYIFTYIGSVLI | 41 | O00160 |